Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor causes pulmonary vasodilation in the rat.

I F McMurtry, K G Morris

    The American Review of Respiratory Disease
    |October 1, 1986
    PubMed
    Summary

    Platelet-activating factor (PAF) causes systemic hypotension and tachycardia. Low-dose PAF reversed hypoxic pulmonary vasoconstriction and dilated pulmonary arteries, indicating complex vasoactive roles.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bacterial contamination of platelet components not detected by BacT/ALERT<sup>®</sup>.

    Transfusion medicine (Oxford, England)·2017
    Same author

    Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.

    British journal of pharmacology·2008
    Same author

    Operational feasibility of routine bacterial monitoring of platelets.

    Transfusion medicine (Oxford, England)·2003
    Same author

    The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.

    The Ulster medical journal·2002
    Same author

    Role of endothelin-1 in lung disease.

    Respiratory research·2001
    Same author

    Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension.

    Respiratory research·2001

    Area of Science:

    • Cardiovascular Physiology
    • Pulmonary Circulation
    • Pharmacology

    Background:

    • Platelet-activating factor (PAF) is typically considered a pulmonary pressor substance.
    • Its vasoactivity at low doses in preconstricted pulmonary beds remains under-investigated.

    Purpose of the Study:

    • To investigate the effects of low-dose PAF on systemic and pulmonary hemodynamics.
    • To assess PAF's role in hypoxic pulmonary vasoconstriction and norepinephrine-induced constriction.

    Main Methods:

    • Conscious, catheterized rats were used to measure hemodynamics during normoxia and hypoxia.
    • Isolated rat lungs and pulmonary artery rings were used to study vasoconstriction and vasodilation.

    Main Results:

    • Low-dose PAF induced transient systemic hypotension and tachycardia in normoxic rats.
    • PAF reversed hypoxic vasoconstriction in isolated lungs and dilated pulmonary artery rings.
    • Endothelium-dependent vasodilation was observed in pulmonary artery rings.

    Conclusions:

    • PAF exhibits complex vasoactive properties, acting as a hypotensive agent and a vasodilator in specific contexts.
    • PAF's effects are dose-dependent and context-specific, influencing both systemic and pulmonary circulation.
    • The endothelium plays a crucial role in PAF-mediated vasodilation in pulmonary arteries.

    Related Experiment Videos